Innate Immunity in Autoimmune Diseases
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Immunology".
Deadline for manuscript submissions: 31 August 2024 | Viewed by 320
Special Issue Editors
Interests: immunology; autoimmune diseases, allergic and inflammatory diseases; biological therapies; basophils; mast cells; fibroblasts; uPAR/uPAR system and its involvement in inflammation; VEGF and its receptors; FPRs receptors; tissue repair processes and tissue remodeling
Special Issues, Collections and Topics in MDPI journals
Interests: immunology; autoimmunity; biological therapies; immune checkpoint inhibitors; immune-related adverse events; autoimmune diseases; neutrophils; macrophages; mast cells; cancer-related inflammation; cancer immunology; tissue repair processes and tissue remodeling
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The innate immune system comprises a variety of factors that influence and participate in virtually all aspects of inflammation and immunity. It is crucial for host defense, but under special conditions, the activation of cells of the innate immune system can break the state of inactivity in auto-reactive cells of the adaptive immune system, thereby provoking autoimmune diseases, such as rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), multiple sclerosis (MS) or inflammatory bowel disease. Multiple steps and multiple components of both the innate and the adaptive immune system are implicated in the generation of autoimmunity and therefore diseases. The innate immune system is crucial to both the beginning and end of autoimmunity. This Special Issue aims to open a discussion on these themes through valuable contributions from pathologists, rheumatologists, dermatologists, and gastroenterologists, creating a common forum for exchanging information and presenting the most cutting edge knowledge in the field. Since IJMS is a journal of molecular science, we will first accept original articles and then outstanding reviews. Clinical submissions with biomolecular experiments and model submissions with at least some validated data (or biological experiments) are also welcomed. Models or clinical studies will not be suitable for our journal, and case reports are not recommended.
Prof. Dr. Francesca Wanda Rossi
Dr. Maria Rosaria Galdiero
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- autoimmune diseases
- basophils
- neutrophils
- eosinophils
- macrophages
- mast cells
- innate receptors
- TLRs
- FPRs
- uPAR/uPA
- T cells
- B cells
- NETs
- biomarkers
- biological therapies
- cytokines
